Elanco Survey Finds Many Pets Live Unprotected Against Preventable Diseases

– Rising Lyme Disease and Leptospirosis Across the Country Puts All Dog Breeds at Risk – GREENFIELD, Ind.–(BUSINESS WIRE)–Amidst a surge of pet adoptions, a new survey released by Elanco finds many pets are insufficiently protected against common diseases like Lyme and leptospirosis. Once largely isolated to wooded regions, the threat of Lyme and lepto … [Read more…]

AmeriHealth Caritas Awarded Contract to Continue Serving Delaware’s Medicaid Population

NEWTOWN SQUARE, Pa.–(BUSINESS WIRE)–#AmeriHealthCaritas—AmeriHealth Caritas Family of Companies announced that its Medicaid plan in Delaware, AmeriHealth Caritas Delaware, has been awarded a contract by the state’s Department of Health and Social Services to continue helping the Diamond State’s Medicaid enrollees access quality health care. “We look forward to continuing to advance our mission with innovative, … [Read more…]

Outlook on the Pharmaceutical Analytical Testing Outsourcing Global Market to 2027 – Increasing focus on Regulation, Safety and Quality is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Analytical Testing Outsourcing Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The Pharmaceutical Analytical Testing Outsourcing Market is expected to register a CAGR of 8.7% during the forecast period, 2022-2027. Companies Mentioned SGS SA Labcorp (Toxikon, Inc) Eurofins Scientific Pace Analytical Services, Inc. … [Read more…]

WALDO Launches Industry-First Hydra Boost Plus Lenses in the United States

These first-of-their-kind and highly anticipated contact lenses are infused with a vitamin-B12 saline solution to provide 30% more hydration and 2x more comfortable wear time. NEW YORK–(BUSINESS WIRE)–WALDO, the innovative eyecare brand, today announces the launch of their Hydra Boost Plus contact lenses, now available at hiwaldo.com. A completely new-to-the-U.S. product, these daily contact lenses … [Read more…]

K Health and Nova Ukraine Partner to Offer Free Virtual Doctor Visits to Ukrainian Refugees

The virtual healthcare platform and Ukrainian humanitarian non-profit will focus on urgent care needs, prescription renewals, and ordering lab tests for thousands of refugees in the U.S. NEW YORK & SAN FRANCISCO–(BUSINESS WIRE)–Digital healthcare company K Health and 501(c)3 registered nonprofit organization Nova Ukraine announced today its partnership to offer free virtual doctor visits to … [Read more…]

European Congress of Radiology (ECR 2022) – Braintale Selected for Oral Presentation of Its Digital Biomarkers’ Platform Technical Potential

STRASBOURG, France–(BUSINESS WIRE)–Braintale, a medtech deciphering white matter, spin off from the Paris Greater Hospitals has been selected for an oral presentation of its abstract during the annual meeting of the European Society of Radiology held in Vienna (Austria) from July 13th to July 17th 2022, demonstrating the technical advances of its digital biomarker platform … [Read more…]

Vital Blood Plasma Production More Than Doubled: Major Project by ZETA Group

GRAZ, Austria–(BUSINESS WIRE)–Blood plasma forms the basis of many life-saving therapies and is also an important building block for future active ingredients in medical research. As the general planner for Octapharma, ZETA implemented an industry leading EPCM project resulting in the doubling of plasma throughput at the Vienna, Austria manufacturing site. The pharmaceutical industry relies … [Read more…]

Insights on the Healthcare IT Integration Global Market to 2028 – by Product, Service, End-user and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Healthcare IT Integration Market, By Product, By Service, By End User, & By Region – Forecast and Analysis 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Healthcare IT Integration Market was valued at USD 3.75 Billion in 2021, and it is expected to reach a value of USD … [Read more…]

AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study

ONL closed the second tranche of a $46.9 million Series B financing round earlier this year ONL now preparing IND filing for a Phase 2 study of ONL1204 Ophthalmic Solution AmbioPharm providing manufacturing support for ONL1204 NORTH AUGUSTA, S.C. & ANN ARBOR, Mich.–(BUSINESS WIRE)–#CPHI–AmbioPharm, a global peptide CDMO, is a key partner in peptide manufacturing … [Read more…]

Feinstein Institutes Awarded $2.5M From NIH to Study Sepsis Drug Targets

MANHASSET, N.Y.–(BUSINESS WIRE)–Sepsis affects at least 1.7 million Americans annually, causing the death of 270,000 patients and 30 percent of all hospital deaths. To better understand the molecular mechanisms of sepsis to develop treatments, The Feinstein Institutes for Medical Research has been awarded a five-year, $2.5 million grant from the National Institutes of Health (NIH). … [Read more…]